Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Your RPS

RPS co-signs letter to prime minister calling for patient safety to be 'at the heart' of Brexit talks

The prime minister, Boris Johnson, has been asked to invite the health secretary to his Brexit strategy committee in a bid to put patient safety at the heart of negotiations.

matt hancock ss 19


The Royal Pharmaceutical Society has asked the prime minister to include the health secretary Matt Hancock (pictured) in his ‘EU exit strategy’ committee

The Royal Pharmaceutical Society (RPS) and 16 other health organisations have written to the prime minister calling on him to “put patient safety and protecting the nation’s health at the heart of Brexit negotiations”.

The letter, co-signed by Sandra Gidley, president of the RPS, asks Boris Johnson to invite health secretary Matt Hancock to join the ‘EU exit strategy’ committee.

Johnson set up the committee in July 2019 to coordinate preparations for the UK to leave the EU at the end of October 2019.

In the letter, the signatories said they are “simply unable to reassure patients that their health and care won’t be negatively impacted by the UK’s exit from the EU”, adding that “despite welcome ongoing engagement with [Department of Health and Social Care], we still have significant concerns about shortages of medical supplies”.

It also points out that the planned EU exit will come just as flu season begins.

“Even a ‘moderate’ flu season places significant additional pressure on the NHS,” the letter says. “Your EU exit strategy must include provision for different flu scenarios, and the secretary of state is well placed to coordinate that.”

Other co-signatories to the letter include Helen Stokes-Lampard, chair of the Royal College of GPs, and Bronagh Scott, director of nursing, policy and practice at the Royal College of Nursing.

The letter comes after leaked government documents warned that exiting the EU without a deal in place will leave the UK’s supply of drugs “particularly vulnerable to severe extended delays” at the Channel crossing.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2019.20206981

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

PJJ Static MPU
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.